Chief Executive Officer
CurrentStructural heart startup focused on heart leaflet modification technologies.
Please complete the CAPTCHA to continue
@comcast.net
✓
2 phones found area 610
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Greg Walters is listed as President/CEO/Founder Excision Medical at Excision Medical, Inc., based in Exton, Pennsylvania, United States. AeroLeads shows a work email signal at comcast.net, phone signal with area code 610, and a matched LinkedIn profile for Greg Walters.
Greg Walters previously worked as Chief Executive Officer at Excision Medical, Inc. and VP of Access and Closure at Teleflex Incorporated. Greg Walters holds Master, Management from Penn State University.
This section adds company-level context without repeating Greg Walters's masked contact details.
AeroLeads found 1 current-domain work email signal for Greg Walters. Compare company email patterns before reaching out.
President/CEO of Excision Medical, a startup company dedicate to advance the field of heart leaflet modification for therapeutic gains during structural heart treatments. Former President/CEO and co-founder of Essential Medical, acquired by Teleflex in 2018.35 year product development professional with extensive experience with designing, developing, and commercializing interventional cardiology products including embolic protection devices, atherectomy catheters, thrombectomy and extraction catheters, chronic total occlusion catheters and femoral closure devices. Experienced with 510K, PMA and Class II and III devices, including all aspects of clinical trials and regulatory submission. Listed inventor on 75+ US and European patents/applications.
Listed skills include Medical Devices, Design Control, Iso 13485, Fda, and 38 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Structural heart startup focused on heart leaflet modification technologies.
Wayne, Pa, Us
Transitioned MANTA and the Essential Medical team to Teleflex.
Exton, Pa, Us
Vascular closure startup focused on creating novel Large Bore closure systems for femoral access.
Led the product development and commercialization of the TriActiv system, supported US clinical studies, gained CE-mark and 510(k) approvals. Developed a local extraction version of TriActiv for use in Carotid arteries. Secured approval and supported US carotid study (PROGUARD) and secured CE mark. Supervised the development of the QuickCat Extraction Catheter, a class-leading aspiration catheter indicated for use for the removal of soft thrombus in the arterial system. Gained US and European approvals. Supervised the development of the ThromCat Thrombus Removal System from concept through European clinical studies and US and European commercialization. Performed due diligence and design assumption activities for the Safe-Cross OCR Chronic Total Occlusion System acquired from Intraluminal Therapeutics. Supervised subsequent development activities. Key managerial role in the divesting of the KNC Endovascular platform (ThromCat, QuickCat and SafeCross) to Spectranetics Corporation for $24 million in May 2007. Identified and participated in business development activities related to opportunities with filters, thrombectomy devices, access catheters, orthopedic, and bariatric surgery instruments.
Managed Angio-Seal R&D activities jointly sponsored by Kensey Nash Corporation and its licensees. Developed winning 6F version. Redesigned the device to be more efficacious and easier to use. Successfully navigated difficult technical, manufacturing, and regulatory issues. Managed the Aegis Vortex program, a device designed to perform protected debulking of SVG lesions.
Key team member during development of the Angio-Seal device. Managed a 10F version of the product. Personally performed sterile surgical procedures and implants. Conducted multiple major design reviews.
Medical device design, including biocompatibility, resorption studies, radiopaque fillers in resorbable materials, collagen production process for Angio-Seal collagen.
Boston, Ma, Us
Designed and built a 150W carbon-monoxide (CO) gas discharge laser for use in laser survivability testing. Conducted laser survivability testing for satellite programs. Graduate of GE's corporate engineering program. Completed extensive leadership training (PLCI and PLCII) and four job rotations.
Boston, Ma, Us
Participated in GE's Advanced Engineering/Leadership Development Programs
Quick answers generated from the profile data available on this page.
Greg Walters works for Excision Medical, Inc..
Greg Walters is listed as President/CEO/Founder Excision Medical at Excision Medical, Inc..
AeroLeads has found 1 work email signal at @comcast.net for Greg Walters at Excision Medical, Inc..
AeroLeads has found 2 phone signal(s) with area code 610 for Greg Walters at Excision Medical, Inc..
Greg Walters is based in Exton, Pennsylvania, United States while working with Excision Medical, Inc..
Greg Walters has worked for Excision Medical, Inc., Teleflex Incorporated, Essential Medical, Inc., Kensey Nash Corporation, and General Electric Company.
You can use AeroLeads to view verified contact signals for Greg Walters at Excision Medical, Inc., including work email, phone, and LinkedIn data when available.
Greg Walters holds Master, Management from Penn State University.
Greg Walters is listed with skills including Medical Devices, Design Control, Iso 13485, Fda, Product Development, R&D, Manufacturing, and Leadership.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts